| __timestamp | Corcept Therapeutics Incorporated | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 18372000 | 189101000 |
| Thursday, January 1, 2015 | 15419000 | 96351000 |
| Friday, January 1, 2016 | 23844000 | 95967000 |
| Sunday, January 1, 2017 | 40376000 | 112171000 |
| Monday, January 1, 2018 | 75247000 | 182257000 |
| Tuesday, January 1, 2019 | 89017000 | 336964000 |
| Wednesday, January 1, 2020 | 114764000 | 547851000 |
| Friday, January 1, 2021 | 113864000 | 693716000 |
| Saturday, January 1, 2022 | 130991000 | 891813000 |
| Sunday, January 1, 2023 | 184353000 | 1044071000 |
| Monday, January 1, 2024 | 910408000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Exelixis, Inc. and Corcept Therapeutics Incorporated have been at the forefront of this race, investing heavily in research and development (R&D) to drive breakthroughs. From 2014 to 2023, Exelixis consistently outpaced Corcept in R&D spending, with a staggering 450% increase, peaking at over $1 billion in 2023. In contrast, Corcept's R&D investment grew by approximately 900%, reaching $184 million in the same year. This significant disparity highlights Exelixis's aggressive strategy to maintain its competitive edge. However, Corcept's steady growth in R&D spending reflects its commitment to innovation, albeit on a smaller scale. As these companies continue to push the boundaries of medical science, their investment strategies offer valuable insights into the future of biotech innovation.
Comparing Innovation Spending: Pfizer Inc. and Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Exelixis, Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs Exelixis, Inc.
R&D Insights: How Neurocrine Biosciences, Inc. and Corcept Therapeutics Incorporated Allocate Funds
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Corcept Therapeutics Incorporated
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Exelixis, Inc. and ACADIA Pharmaceuticals Inc.
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Comparing Innovation Spending: Corcept Therapeutics Incorporated and Opthea Limited
Research and Development Investment: Corcept Therapeutics Incorporated vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Veracyte, Inc.